The most common include nausea, vomiting, diarrhea, and mild abdominal discomfort
Get breaking news and the latest developments from South Africa and beyond as they happen
The success of GLP-1 receptor agonists depends on maintaining a stable concentration of active peptide in the bloodstream
Semaglutide was added in 2024, and markers of tirzepatide were added from 1 January 2026, both monitored in and out of competition
In a study of Rybelsus (the earlier formulation of the Ozempic pill, also with all participants eating a standardized breakfast), people reported fewer cravings and better control over their eating by the three-month mark
It's a tri-agonist, meaning it activates three different receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon (GCG) receptor